Skip to main content
Top
Published in: AIDS and Behavior 7/2012

Open Access 01-10-2012 | Original Paper

HIV Incidence Among Non-Pregnant Women Living in Selected Rural, Semi-Rural and Urban Areas in Kwazulu-Natal, South Africa

Authors: Gita Ramjee, Handan Wand, Claire Whitaker, Sheena McCormack, Nancy Padian, Cliff Kelly, Andrew Nunn

Published in: AIDS and Behavior | Issue 7/2012

Login to get access

Abstract

The province of KwaZulu-Natal has the highest prevalence of HIV in South Africa, particularly among young women. In order to more closely examine the HIV prevalence and incidence in non-pregnant women from rural, semi-rural and urban areas, data from 5,753 women screened for enrolment into three HIV prevention studies were combined and analysed. The prevalence of HIV infection was 43% at screening. HIV incidence among the 2,523 enrolled HIV-negative women was determined every quarter, and sexual behaviour and socio-demographic data were collected as per respective protocols. During follow-up, 211 women seroconverted (6.6/100 women years). Multivariate analysis found that seroconversion rates were highest among women who were ≤24 years old, single and not cohabiting, and who had incident sexually transmitted infections. The epidemic in KwaZulu-Natal calls for targeted HIV prevention interventions among those at highest risk of acquiring or transmitting infection.
Literature
1.
go back to reference UNAIDS. Report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS; 2008. UNAIDS. Report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS; 2008.
2.
go back to reference Chen L, Jha P, Stirling B, et al. Sexual risk factors for HIV infection in early and advanced HIV epidemics in sub-Saharan Africa: systematic overview of 68 epidemiological studies. PLoS One. 2007;2(10):e1001.PubMedCrossRef Chen L, Jha P, Stirling B, et al. Sexual risk factors for HIV infection in early and advanced HIV epidemics in sub-Saharan Africa: systematic overview of 68 epidemiological studies. PLoS One. 2007;2(10):e1001.PubMedCrossRef
3.
go back to reference Dunkle K. Transactional sex among women in Soweto, South Africa: prevalence, risk factors and association with HIV infection. Soc Sci Med. 2004;59(8):1581–92.PubMedCrossRef Dunkle K. Transactional sex among women in Soweto, South Africa: prevalence, risk factors and association with HIV infection. Soc Sci Med. 2004;59(8):1581–92.PubMedCrossRef
4.
go back to reference Côté A, Sobela F, Dzokoto A, et al. Transactional sex is the driving force in the dynamics of HIV in Accra, Ghana. AIDS. 2004;18(6):917.PubMedCrossRef Côté A, Sobela F, Dzokoto A, et al. Transactional sex is the driving force in the dynamics of HIV in Accra, Ghana. AIDS. 2004;18(6):917.PubMedCrossRef
6.
go back to reference Halperin D, Epstein H. Why is HIV prevalence so severe in southern Africa? The role of multiple concurrent partnerships and lack of male circumcision: implications for AIDS prevention. South Afr J HIV Med. 2007;8:19–25. Halperin D, Epstein H. Why is HIV prevalence so severe in southern Africa? The role of multiple concurrent partnerships and lack of male circumcision: implications for AIDS prevention. South Afr J HIV Med. 2007;8:19–25.
7.
go back to reference Cohen M, Hoffman I, Royce R, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet. 1997;349(9069):1868–73.PubMedCrossRef Cohen M, Hoffman I, Royce R, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet. 1997;349(9069):1868–73.PubMedCrossRef
8.
go back to reference Ramjee G, Williams B, Gouws E, Van Dyck E, Deken B, Karim S. The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa. J Acquir Immune Defic Syndr. 2005;39(3):333.PubMedCrossRef Ramjee G, Williams B, Gouws E, Van Dyck E, Deken B, Karim S. The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa. J Acquir Immune Defic Syndr. 2005;39(3):333.PubMedCrossRef
9.
go back to reference Weiss H, Quigley M, Hayes R. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 2000;14(15):2361.PubMedCrossRef Weiss H, Quigley M, Hayes R. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 2000;14(15):2361.PubMedCrossRef
10.
go back to reference Siegfried N, Muller M, Deeks J, et al. HIV and male circumcision—a systematic review with assessment of the quality of studies. Lancet Infect Dis. 2005;5(3):165–73.PubMed Siegfried N, Muller M, Deeks J, et al. HIV and male circumcision—a systematic review with assessment of the quality of studies. Lancet Infect Dis. 2005;5(3):165–73.PubMed
11.
go back to reference Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D. The health and health system of South Africa: historical roots of current public health challenges. Lancet. 2009;374(9692):817–34.PubMedCrossRef Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D. The health and health system of South Africa: historical roots of current public health challenges. Lancet. 2009;374(9692):817–34.PubMedCrossRef
12.
go back to reference Lurie M, Williams B, Zuma K, et al. Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS. 2003;17(15):2245–52.PubMedCrossRef Lurie M, Williams B, Zuma K, et al. Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS. 2003;17(15):2245–52.PubMedCrossRef
13.
go back to reference Lurie M, Williams B, Zuma K, et al. The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. Sex Transm Dis. 2003;30(2):149–56.PubMedCrossRef Lurie M, Williams B, Zuma K, et al. The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. Sex Transm Dis. 2003;30(2):149–56.PubMedCrossRef
14.
go back to reference Shisana O, Rehle T, Simbayi LC, et al. South African national HIV prevalence, incidence, behaviour and communication survey 2008: a turning tide among teenagers?. Cape Town: HSRC Press; 2009. Shisana O, Rehle T, Simbayi LC, et al. South African national HIV prevalence, incidence, behaviour and communication survey 2008: a turning tide among teenagers?. Cape Town: HSRC Press; 2009.
15.
go back to reference Department of Health. National antenatal sentinel HIV and syphilis prevalence survey, South Africa. Pretoria: National Department of Health; 2008. Department of Health. National antenatal sentinel HIV and syphilis prevalence survey, South Africa. Pretoria: National Department of Health; 2008.
16.
go back to reference Ramjee G, Kapiga S, Weiss S, et al. The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials—experience from the HPTN 055 study. J Acquir Immune Defic Syndr. 2008;47(1):93–100.PubMedCrossRef Ramjee G, Kapiga S, Weiss S, et al. The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials—experience from the HPTN 055 study. J Acquir Immune Defic Syndr. 2008;47(1):93–100.PubMedCrossRef
17.
go back to reference Shisana O, Rehle T, Simbayi LC, et al. South African national HIV prevalence, HIV incidence, behaviour and communication survey 2005. Cape Town: HSRC Press; 2005. Shisana O, Rehle T, Simbayi LC, et al. South African national HIV prevalence, HIV incidence, behaviour and communication survey 2005. Cape Town: HSRC Press; 2005.
18.
go back to reference Padian N, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007;370(9583):251–61.PubMedCrossRef Padian N, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007;370(9583):251–61.PubMedCrossRef
19.
go back to reference Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.PubMedCrossRef Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.PubMedCrossRef
20.
go back to reference van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002;360(9338):971–7.PubMedCrossRef van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002;360(9338):971–7.PubMedCrossRef
21.
go back to reference Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9654):1977–87.PubMedCrossRef Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9654):1977–87.PubMedCrossRef
22.
go back to reference Feldblum P, Adeiga A, Bakare R, et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS One. 2008;3(1):e1471.CrossRef Feldblum P, Adeiga A, Bakare R, et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS One. 2008;3(1):e1471.CrossRef
23.
go back to reference van Damme L, Govinden R, Mirembe F, et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med. 2008;359(5):463–72.PubMedCrossRef van Damme L, Govinden R, Mirembe F, et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med. 2008;359(5):463–72.PubMedCrossRef
24.
go back to reference Abdool Karim S, Coletti A, Richardson B, et al. Safety and effectiveness of vaginal microbicides BufferGel and 0.5% PRO 2000 gel for the prevention of HIV infection in women: results of the HPTN 035 trial [Abstract 48LB]. 16th Conference on Retroviruses and Opportunistic Infections. Montréal, 8–11 February, 2009. Abdool Karim S, Coletti A, Richardson B, et al. Safety and effectiveness of vaginal microbicides BufferGel and 0.5% PRO 2000 gel for the prevention of HIV infection in women: results of the HPTN 035 trial [Abstract 48LB]. 16th Conference on Retroviruses and Opportunistic Infections. Montréal, 8–11 February, 2009.
25.
go back to reference McCormack S, Ramjee G, Kamali A, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet. 2010;376(9749):1329–37.PubMedCrossRef McCormack S, Ramjee G, Kamali A, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet. 2010;376(9749):1329–37.PubMedCrossRef
26.
go back to reference Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses. 2002;18(4):295–307.PubMedCrossRef Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses. 2002;18(4):295–307.PubMedCrossRef
27.
go back to reference Suligoi B, Massi M, Galli C, et al. Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J Acquir Immune Defic Syndr. 2003;32(4):424–8.PubMedCrossRef Suligoi B, Massi M, Galli C, et al. Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J Acquir Immune Defic Syndr. 2003;32(4):424–8.PubMedCrossRef
28.
go back to reference van de Wijgert J, Braunstein S, Vyankandondera J, et al. Cross-sectional estimation of HIV incidence by BED-CEIA and avidity index assays in vaginal microbicide preparedness studies in Rwanda and South Africa [Abstract no. 365]. Pittsburgh: Microbicides 2010; 2010. van de Wijgert J, Braunstein S, Vyankandondera J, et al. Cross-sectional estimation of HIV incidence by BED-CEIA and avidity index assays in vaginal microbicide preparedness studies in Rwanda and South Africa [Abstract no. 365]. Pittsburgh: Microbicides 2010; 2010.
29.
go back to reference Truong H-HM, Kellogg T, Louie B, Klausner J, Dilley J, McFarland W. Recent HIV-1 infection detection: comparison of incidence estimates derived by laboratory assays and repeat testing data. J Acquir Immune Defic Syndr. 2009;51(4):502–5.PubMedCrossRef Truong H-HM, Kellogg T, Louie B, Klausner J, Dilley J, McFarland W. Recent HIV-1 infection detection: comparison of incidence estimates derived by laboratory assays and repeat testing data. J Acquir Immune Defic Syndr. 2009;51(4):502–5.PubMedCrossRef
30.
go back to reference UNAIDS Reference Group for Estimates MaP. Statement on the use of the BED-Assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. 2005. UNAIDS Reference Group for Estimates MaP. Statement on the use of the BED-Assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. 2005.
31.
go back to reference Brookmeyer R. Measuring the HIV/AIDS epidemic: approaches and challenges. Epidemiol Rev. 2010;32(1):26–37.PubMedCrossRef Brookmeyer R. Measuring the HIV/AIDS epidemic: approaches and challenges. Epidemiol Rev. 2010;32(1):26–37.PubMedCrossRef
32.
go back to reference Nunn A, McCormack S, Crook A, Pool R, Rutterford C, Hayes R. Microbicides development programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials. 2009;10(1):99.PubMedCrossRef Nunn A, McCormack S, Crook A, Pool R, Rutterford C, Hayes R. Microbicides development programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials. 2009;10(1):99.PubMedCrossRef
33.
go back to reference Rehle T, Shisana O, Pillay V, Zuma K, Puren A, Parker W. National HIV incidence measures—new insights into the South African epidemic. S Afr Med J. 2007;97(3):194–9.PubMed Rehle T, Shisana O, Pillay V, Zuma K, Puren A, Parker W. National HIV incidence measures—new insights into the South African epidemic. S Afr Med J. 2007;97(3):194–9.PubMed
34.
go back to reference Rehle TM, Hallett TB, Shisana O, et al. A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One. 2010;5(6):e11094.PubMedCrossRef Rehle TM, Hallett TB, Shisana O, et al. A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One. 2010;5(6):e11094.PubMedCrossRef
35.
go back to reference Abdool Karim Q, Kharsany AB, Frohlich JA, et al. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. Int J Epidemiol. 2010. Abdool Karim Q, Kharsany AB, Frohlich JA, et al. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. Int J Epidemiol. 2010.
36.
go back to reference Chigwedere P, Seage GRI, Gruskin S, Lee T-H, Essex M. Estimating the lost benefits of antiretroviral drug use in South Africa. J Acquir Immune Defic Syndr. 2008;49(4):410–5.PubMedCrossRef Chigwedere P, Seage GRI, Gruskin S, Lee T-H, Essex M. Estimating the lost benefits of antiretroviral drug use in South Africa. J Acquir Immune Defic Syndr. 2008;49(4):410–5.PubMedCrossRef
37.
go back to reference Bärnighausen T, Tanser F, Gqwede Z, Mbizana C, Herbst K, Newell M-L. High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study. AIDS. 2008;22(1):139–44.PubMedCrossRef Bärnighausen T, Tanser F, Gqwede Z, Mbizana C, Herbst K, Newell M-L. High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study. AIDS. 2008;22(1):139–44.PubMedCrossRef
38.
go back to reference Maharaj P, Cleland J. Condom use within marital and cohabiting partnerships in KwaZulu-Natal, South Africa. Stud Fam Plann. 2004;35(2):116–24.PubMedCrossRef Maharaj P, Cleland J. Condom use within marital and cohabiting partnerships in KwaZulu-Natal, South Africa. Stud Fam Plann. 2004;35(2):116–24.PubMedCrossRef
39.
go back to reference Luke N. Age and economic asymmetries in the sexual relationships of adolescent girls in sub-Saharan Africa. Stud Fam Plann. 2003;34(2):67–86.PubMedCrossRef Luke N. Age and economic asymmetries in the sexual relationships of adolescent girls in sub-Saharan Africa. Stud Fam Plann. 2003;34(2):67–86.PubMedCrossRef
40.
go back to reference Hunter M. The materiality of sex: thinking beyond prostitution. Afr Stud. 2002;61(1):99–120.CrossRef Hunter M. The materiality of sex: thinking beyond prostitution. Afr Stud. 2002;61(1):99–120.CrossRef
41.
go back to reference Maharaj P. Patterns of condom use: perspectives of men in KwaZulu-Natal, South Africa. Dev South Afr. 2005;22(2):187–97.CrossRef Maharaj P. Patterns of condom use: perspectives of men in KwaZulu-Natal, South Africa. Dev South Afr. 2005;22(2):187–97.CrossRef
42.
go back to reference Hargreaves J, Glynn J. Educational attainment and HIV-1 infection in developing countries: a systematic review. Trop Med Int Health. 2002;7(6):489–98.PubMedCrossRef Hargreaves J, Glynn J. Educational attainment and HIV-1 infection in developing countries: a systematic review. Trop Med Int Health. 2002;7(6):489–98.PubMedCrossRef
43.
go back to reference Lurie M, Pronyk P, de Moor E, et al. Sexual behavior and reproductive health among HIV-infected patients in urban and rural South Africa. J Acquir Immune Defic Syndr. 2008;47(4):484–93.PubMedCrossRef Lurie M, Pronyk P, de Moor E, et al. Sexual behavior and reproductive health among HIV-infected patients in urban and rural South Africa. J Acquir Immune Defic Syndr. 2008;47(4):484–93.PubMedCrossRef
44.
go back to reference Laga M, Schwärtlander B, Pisani E, Sow PS, Caraël M. To stem HIV in Africa, prevent transmission to young women. AIDS. 2001;15:931–4.PubMedCrossRef Laga M, Schwärtlander B, Pisani E, Sow PS, Caraël M. To stem HIV in Africa, prevent transmission to young women. AIDS. 2001;15:931–4.PubMedCrossRef
45.
go back to reference Greig F, Koopman C. Multilevel analysis of women’s empowerment and HIV prevention: quantitative survey results from a preliminary study in Botswana. AIDS Behav. 2003;7(2):195–208.PubMedCrossRef Greig F, Koopman C. Multilevel analysis of women’s empowerment and HIV prevention: quantitative survey results from a preliminary study in Botswana. AIDS Behav. 2003;7(2):195–208.PubMedCrossRef
46.
go back to reference Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75(1):3–17.PubMedCrossRef Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75(1):3–17.PubMedCrossRef
Metadata
Title
HIV Incidence Among Non-Pregnant Women Living in Selected Rural, Semi-Rural and Urban Areas in Kwazulu-Natal, South Africa
Authors
Gita Ramjee
Handan Wand
Claire Whitaker
Sheena McCormack
Nancy Padian
Cliff Kelly
Andrew Nunn
Publication date
01-10-2012
Publisher
Springer US
Published in
AIDS and Behavior / Issue 7/2012
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-0043-7

Other articles of this Issue 7/2012

AIDS and Behavior 7/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.